Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)
Open Access
- 1 December 1997
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (11), 1509-1517
- https://doi.org/10.1038/bjc.1997.586
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Chemotherapy in the management of patients with inoperable non-small cell lung cancer.1996
- Treatment of Stage III-IV Non-Small-Cell Lung Carcinoma with Vinorelbine in Combination with Ifosfamide plus MESNA: A Study by the Southern Italy Oncology Group (GOIM)American Journal of Clinical Oncology, 1996
- Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancerCancer Chemotherapy and Pharmacology, 1996
- Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancerAnnals of Oncology, 1995
- Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.)Annals of Oncology, 1995
- Treatment of Non-Small Cell Lung Cancer with Ifosfamide (IFO) + 4’-Epiadriamycin (EPI) + Platinum vs. IFO + EPI: A GETLAC StudyOncology, 1995
- Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trialAnnals of Oncology, 1994
- Extended administration of oral etoposide and oral cyclophosphamide for the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1993
- Reporting results of cancer treatmentCancer, 1981
- Prognostic Factors for Survival in Patients With Inoperable Lung Cancer2JNCI Journal of the National Cancer Institute, 1980